ArticleScientific reports2025
Analysis of full-term neonatal eye disease screening results and trends from 2016 to 2023.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To analyze the results and trends of common eye diseases from full-term neonatal eye screenings conducted between 2016 and 2023. A retrospective study was conducted on 17,378 full-term neonates screened for eye diseases at CiXi Maternity&Child Health Care Hospital from January 2016 to December 2023. Statistical analysis and Joinpoint regression were used to assess trends in eye disease incidence, measured by the Average Annual Percent Change (AAPC). Among 17,378 full-term neonates, 5,986 (34.45%) had abnormal eye screening results: Retinal hemorrhage (3,274 cases, 18.84%), white spots (1,440 cases, 8.29%), exudates (943 cases, 5.43%), pigment abnormalities (437 cases, 2.51%), and lesions resembling Familial Exudative Vitreoretinopathy (FEVR-like) (228 cases, 1.31%). Retinal hemorrhage (χ² = 1840.390, P = 0.000) and exudates (χ² = 10.488, P = 0.001) were more common in neonates born via vaginal delivery. From 2016 to 2023, the overall abnormality rate declined (AAPC = -6.9%, 95% CI: -12.1% to -1.5%, P = 0.0211). Trends included: Retinal hemorrhage (AAPC = -3.2%, 95% CI: -6.4% to 0.0%, P = 0.0499) and pigment abnormalities (AAPC = -25.4%, 95% CI: -42.8% to -3.0%, P = 0.0342). Other retinal abnormalities showed no significant trends (all P > 0.05). Eye disease due to fundus lesions From 2016 to 2023, The overall incidence of fundus lesions in full-term neonates showed a declining trend. Vaginal delivery is a risk factor for retinal hemorrhages and retinal exudation in full-term neonates. We found a strong association between cytomegalovirus infection and retinal exudation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.